LAKE FOREST, Ill., Aug. 15, 2011 /PRNewswire/ -- PharMEDium Services, LLC, market leader for customized pharmacy sterile compounding for hospital intravenous and epidural therapies, launched its new website, www.pharmedium.com, which now provides updates on drug shortages, patient safety and ready-to-use pharmacy compounding services. Hospital customers can easily obtain valuable information on PharMEDium's broad range of services designed to reduce waste, improve efficiency and enhance patient safety. The PharMEDium website design provides information necessary to facilitate a hospital's selection of the right partner for compounded sterile preparations and demonstrates the qualities to look for when assessing a possible outsourced pharmacy sterile compounding service provider. The result of choosing a partner that ranks high in regulatory compliance, quality and patient safety measures, medication administration safety features and service excellence is the selection of a reputable and reliable outsourced pharmacy sterile compounding service provider.
Amy Langan, VP of Marketing and Business Development, commented, "PharMEDium's new website demonstrates our ongoing commitment to improve on our customer service experience providing innovative customized pharmacy sterile compounding solutions to the market we serve. We conducted extensive customer research to ensure that our website design and development met the mark for enhancing patient safety. We succeeded by making valuable service information easier to locate, use and refer to at the touch of a key."
PharMEDium hospital customers want easy access to drug shortage information and ready-to-use pharmacy compounding service updates as well as convenient online ordering capability for DEA Schedule II Controlled Substances. Central to PharMEDium Services is www.pharmedium.com, where convenient online ordering for customers resides. Online ordering has been propelled to the next generation by the establishment of the Controlled Substance Online System "CSOS" for ordering DEA Schedule II Controlled Substances.
David N. Jonas, Chairman and CEO of PharMEDium Healthcare Corporation stated, "PharMEDium's launch of an enhanced website experience is yet another example of our commitment to provide hospital customers with continuous service improvements. Our wide-range of pharmacy compounding services, innovative processes and customer service demonstrates our continued commitment to be the national leader in hospital outsourced compounding services."
PharMEDium is the national leading provider of customized pharmacy sterile compounding for hospital intravenous and epidural therapies. The PharMEDium network of state licensed and federally registered compounding centers provides trusted solutions to hospitals throughout the United States. PharMEDium complies with all applicable state laws and FDA regulations, including USP Chapter (797), and DEA requirements. For more information on PharMEDium, visit www.pharmedium.com.
SOURCE PharMEDium Services, LLC
